MedicaidCoverageMedium impact
KMAP BULLETIN: Preferred Drug List Update – August 2025
Kansas Medicaid (KanCare)·KS · Pharmacy, Endocrinology, Family Medicine +2 more·Pharmacy
Effective date
Aug 1, 2025
We identified it
Jun 21, 2026
Summary
KMAP (Kansas Medicaid) has updated their Preferred Drug List effective August 1, 2025. Eight medications including Khindivi, Brynovin, Merilog insulin products, and others will become Non-Preferred, while Valsartan Oral Solution will be added as Preferred.
Action Required
By August 1, 2025: Pharmacy and billing teams must update prior authorization requirements for newly non-preferred medications (Khindivi, Brynovin, Merilog Solostar, Merilog, Xifyrm, Ryzneuta, Xphozah, Yutrepia). Review patient medication lists and coordinate with providers for potential therapeutic substitutions to preferred alternatives. Update billing system to reflect new preferred status of Valsartan Oral Solution (Labeler 72888).